The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS INC | COM | 35104E100 | 7,257,293 | 345,750 | SH | SOLE | 345,750 | 0 | 0 | |||
| ABCELLERA BIOLOGICS INC | COM | 00288U106 | 592,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| ACELYRIN INC | COM | 00445A100 | 6,967,800 | 1,580,000 | SH | SOLE | 1,580,000 | 0 | 0 | |||
| AEROVATE THERAPEUTICS INC | COM | 008064107 | 730,400 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | |||
| ALIGOS THERAPEUTICS INC | COM | 01626L105 | 441,000 | 1,260,000 | SH | SOLE | 1,260,000 | 0 | 0 | |||
| ALLAKOS INC | COM | 01671P100 | 2,780,000 | 2,780,000 | SH | SOLE | 2,780,000 | 0 | 0 | |||
| APPLIED THERAPEUTICS INC' | COM | 03828A101 | 7,845,600 | 1,680,000 | SH | SOLE | 1,680,000 | 0 | 0 | |||
| ARVINAS INC | COM | 04335A105 | 14,774,100 | 555,000 | SH | SOLE | 555,000 | 0 | 0 | |||
| BIODESIX INC | COM | 09075X108 | 6,150,600 | 4,020,000 | SH | SOLE | 4,020,000 | 0 | 0 | |||
| CARGO THERAPEUTICS INC | COM | 14179K101 | 9,124,594 | 555,700 | SH | SOLE | 555,700 | 0 | 0 | |||
| CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 9,913,600 | 640,000 | SH | SOLE | 640,000 | 0 | 0 | |||
| CODEXIS INC | COM | 192005106 | 10,710,500 | 3,455,000 | SH | SOLE | 3,455,000 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 10,754,730 | 198,500 | SH | SOLE | 198,500 | 0 | 0 | |||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 686,750 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | |||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 10,445,800 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | |||
| ETON PHARMACEUTICALS INC | COM | 29772L108 | 7,879,550 | 2,395,000 | SH | SOLE | 2,395,000 | 0 | 0 | |||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 1,767,000 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | |||
| GOSSAMER BIO INC | COM | 38341P102 | 3,522,519 | 3,910,000 | SH | SOLE | 3,910,000 | 0 | 0 | |||
| GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 3,957,752 | 8,000,000 | PRN | SOLE | 8,000,000 | 0 | 0 | |||
| HARROW HEALTH INC | COM | 415858109 | 83,351,100 | 3,990,000 | SH | SOLE | 3,990,000 | 0 | 0 | |||
| IBIO INC | COM NEW | 451033708 | 791,250 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | |||
| IMMUNOME INC | COM | 45257U108 | 13,340,250 | 1,102,500 | SH | SOLE | 1,102,500 | 0 | 0 | |||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 4,878,840 | 218,000 | SH | SOLE | 218,000 | 0 | 0 | |||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 7,193,940 | 897,000 | SH | SOLE | 897,000 | 0 | 0 | |||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | 8,898,400 | 392,000 | SH | SOLE | 392,000 | 0 | 0 | |||
| KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 3,747,156 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | |||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 1,236,330 | 1,425,000 | SH | SOLE | 1,425,000 | 0 | 0 | |||
| KEROS THERAPEUTICS INC | COM | 492327101 | 16,794,750 | 367,500 | SH | SOLE | 367,500 | 0 | 0 | |||
| LEXICON PHARMACEUTICALS INC | COM NEW | 528872302 | 3,150,000 | 1,875,000 | SH | SOLE | 1,875,000 | 0 | 0 | |||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 3,900,000 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | |||
| LYELL IMMUNOPHARMA INC | COM | 55083R104 | 2,421,500 | 1,670,000 | SH | SOLE | 1,670,000 | 0 | 0 | |||
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 6,051,150 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | |||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 8,743,027 | 418,928 | SH | SOLE | 418,928 | 0 | 0 | |||
| NUVALENT INC | COM | 670703107 | 4,498,498 | 59,300 | SH | SOLE | 59,300 | 0 | 0 | |||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 36,303,300 | 5,307,500 | SH | SOLE | 5,307,500 | 0 | 0 | |||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 769,500 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | |||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 3,638,250 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | |||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 5,299,803 | 2,304,262 | SH | SOLE | 2,304,262 | 0 | 0 | |||
| REGULUS THERAPEUTICS INC | COM | 75915K309 | 2,632,875 | 1,475,000 | SH | SOLE | 1,475,000 | 0 | 0 | |||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 1,800,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
| RENEO PHARMACEUTICALS INC | COM | 75974E103 | 249,150 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | |||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 21,145,900 | 515,000 | SH | SOLE | 515,000 | 0 | 0 | |||
| SAVARA INC | COM | 805111101 | 2,881,289 | 714,960 | SH | SOLE | 714,960 | 0 | 0 | |||
| SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 4,465,686 | 865,443 | SH | SOLE | 865,443 | 0 | 0 | |||
| TG THERAPEUTICS INC | COM | 88322Q108 | 40,561,200 | 2,280,000 | SH | SOLE | 2,280,000 | 0 | 0 | |||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 7,882,100 | 2,645,000 | SH | SOLE | 2,645,000 | 0 | 0 | |||
| UROGEN PHARMA LTD | COM | M96088105 | 6,913,360 | 412,000 | SH | SOLE | 412,000 | 0 | 0 | |||
| VAXCYTE INC | COM | 92243G108 | 6,418,350 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 2,748,900 | 1,190,000 | SH | SOLE | 1,190,000 | 0 | 0 | |||
| VERASTEM INC | COM NEW | 92337C203 | 2,726,700 | 915,000 | SH | SOLE | 915,000 | 0 | 0 | |||
| XOMA CORP DEL | COM NEW | 98419J206 | 5,922,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||